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Abstract
Background: The benefit of screening for decreasing the risk of death from colorectal cancer (CRC) has been
shown, yet many patients in primary care are still not undergoing screening according to guidelines. There are
known variations in delivery of preventive health care services among primary care physicians. This study
compared self-reported CRC screening rates and patient awareness of the need for CRC screening of patients
receiving care from family medicine (FPs) vs. internal medicine (internists) physicians.
Methods: Nationally representative sample of non-institutionalized beneficiaries who received medical care from
FPs or internists in 2006 (using Medicare Current Beneficiary Survey). The main outcome was the percentage of
patients screened in 2007. We also examined the percentage of patients offered screening.
Results: Patients of FPs, compared to those of internists, were less likely to have received an FOBT kit or
undergone home FOBT, even after accounting for patients’ characteristics. Compared to internists, FPs’ patients
were more likely to have heard of colonoscopy, but were less likely to receive a screening colonoscopy
recommendation (18% vs. 27%), or undergo a colonoscopy (43% vs. 46%, adjusted odds ratios [AOR], 95%
confidence interval [CI]– 0.65, 0.51-0.81) or any CRC screening (52% vs. 60%, AOR, CI–0.80, 0.68-0.94). Among
subgroups examined, higher income beneficiaries receiving care from internists had the highest screening rate
(68%), while disabled beneficiaries receiving care from FPs had the lowest screening rate (34%).
Conclusion: Patients cared for by FPs had a lower rate of screening compared to those cared for by internists,
despite equal or higher levels of awareness; a difference that remained statistically significant after accounting for
socioeconomic status and access to healthcare. Both groups of patients remained below the national goal of
70 percent.
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Background
Screening has been shown to decrease the risk of mortal-
ity for colorectal cancer (CRC) [1-4]. Although the use of
CRC screening has increased in the US, particularly over
the past decade [5,6], for many groups, screening rates
are below the Healthy People goal of 70% [7]. Primary
care physicians (PCPs) play an important role in the
delivery of CRC screening services [6,8-12] by advising,
recommending, performing and/or referring patients for
screening [13]. It is therefore not surprising that studies
have consistently reported a strong association between
healthcare provider recommendations for and receipt of
CRC screening for persons with a usual source of care
[8,9,14]. This supports the hypothesis that variations in
the delivery of CRC screening services among PCPs have
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any medium, provided the original work is properly cited.a negative impact on efforts to increase screening rates in
the US. However, there are very few published studies on
PCP-related variations in CRC screening that simulta-
neously assess screening rates and physicians’ delivery of
screening, as reported by patients.
Despite the limited literature on PCP-related variation in
screening, the existing evidence about differing quality of
preventive health care among PCPs [15-18] suggests that
similar differences in quality of CRC screening may contri-
bute to underuse of screening in some populations. One
study, which included analyses on CRC testing by PCP
specialty, found that patients receiving their usual routine
care from family/general practitioners were less likely to
have had CRC testing than those receiving care from a
general internists [18]. However, the findings of that study
were limited by the use of insurance claims data alone and
the exclusion of fecal occult blood test (FOBT) use in the
definition of CRC screening. Thus, there is paucity of pub-
lished studies that simultaneously addressed both a
patient’s awareness and use of CRC screening services and
a physician’s recommendation and delivery of CRC
screening through interviews with patients. This would
lead to a better understanding if it is clarified whether or
not low rates of screening are the result of patient factors
such as education or income or a physician’s failure to
offer screening. Additionally, understanding the variations
in screening practices according to PCP specialties will
provide insights into some of the reasons behind subopti-
mal rates of CRC screening in the US. A key question is
whether a particular PCP specialty group has achieved the
US national CRC screening objectives.
In this study, we compared the CRC screening practices
of patients receiving care from FPs to those receiving care
from internists. We examined individual’sa w a r e n e s so f
CRC screening tests and the utilization of such screening,
according to whether the patient received their usual med-
ical care from an FP or internist, and related those differ-
ences to patient factors.
Methods
The data for this study were obtained from the Medicare
Current Beneficiary Survey (MCBS) and matched Medi-
care claims. The design and data collection methods for
the MCBS are described in detail previously [19,20]. In
brief, the MCBS is an ongoing annual survey with four-
year rotating cohorts of nationally representative samples
of Medicare beneficiaries who are interviewed in-person
three times a year [19]. We used data on non-institutio-
nalized beneficiaries who were 50-75 years of age at the
beginning of 2006, were continuously enrolled in Medi-
care, participated in the interviews in both 2006 and
2007, and had no personal history of renal disease or
CRC in 2006 or 2007. Our study population therefore
also included persons 50-64 years of age who were in
Medicare as a result of disability. Our upper age cutoff
was based on current U.S. Preventive Services Task Force
CRC screening guidelines [21,22]. This study was
reviewed by the institutional review board (IRB) of the
University of Massachusetts Medical School (Worcester,
MA) and was considered exempt from a full IRB review.
Data elements
Each survey year, the MCBS collects data on participants
including age, gender and marital status; residence in
metropolitan service areas (MSA); highest level of educa-
tional achievement (less than high school vs. others);
household income (<$25,000 vs. others); primary language
(English vs. all other languages); the type of health insur-
ance coverage (supplemental vs. no supplemental insur-
ance); and delaying medical care due to cost [19,20].
These factors are known to be associated with use of CRC
screening [23]. Additional data collected includes benefi-
ciary employment, history of non-skin cancers and self-
rated general health status (which was used as proxy for
wellness to undergo screening).
Specialty of the usual care primary care physician
The primary predictor in our analyses was the specialty of
PCP that a beneficiary usually sees for medical care (FP vs.
internist). During the fall of each year, the MCBS collects
information about the “particular medical person or ...
clinic [a beneficiary] usually goes to when [he/she is]... sick
or [for] advice about ... health”, and the specialty of the
particular doctor he/she usually sees. Among the poten-
tially eligible subjects for this study, 1,922 patients
reported their usual physician was either an FP or inter-
nist. We then used the Unique Physician Identification
Numbers from Medicare claims to match 1,354 other
patients to an FP or internist. When both specialties were
identified for a particular subject (n = 208), the PCP with
the greater number of services rendered was assigned: no
ties were observed [24].
Measures of colorectal cancer awareness and screening
In the fall of 2007, MCBS respondents 50 years of age or
older, who did not report a history of CRC, were asked
whether they had ever had CRC screening test (sigmoido-
scopy, colonoscopy, and/or a home FOBT), and if so, the
date of the most recent test (as shown in Figure 1.) We
defined a nominal screening variable by first considering
the receipt of a sigmoidoscopy/colonoscopy within five
years of the interview date and then FOBT within one
year, in a mutually exclusive manner. We also created a
combined outcome of CRC screening defined as receiving
colonoscopy or sigmoidoscopy within 5 years and/or
FOBT within one year. This approach was based on how
questions were asked on the MCBS as described pre-
viously [20]. Respondents were also asked if they were
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those who had received an FOBT kit were then asked if
they had returned the last kit (categorized as yes vs. no).
Patients who had not previously received a kit were asked
if they had “ever heard of this home testing kit” (categor-
ized as yes vs. no). In addition to questions on FOBT use,
those who had not previously undergone a colonoscopy or
sigmoidoscopy were asked if they had “ever heard of” sig-
moidoscopy/colonoscopy and if so, whether his/her physi-
cian recommended that he/she should have the exam
(categorized as yes vs. no). Participants who had previously
heard of or received CRC screening were asked: “Before
today, did you know that Medicare now helps pay for the
cost of screening tests”.
Data analyses
Two-by-two contingency tables and the Wald chi-square
test were used to compare beneficiaries’ characteristics,
awareness and knowledge of CRC screening according
to PCP specialty (FP vs. internist). Specifically, we exam-
ined differences in awareness of CRC, colonoscopy/sig-
moidoscopy, home FOBT kit, or Medicare’s coverage for
CRC screening. Analyses on knowledge of Medicare’s
coverage for CRC screening were stratified according to
Medicare Beneficiaries 
eligible for study, 
n=3,276 
Has a doctor or other health professional ever 
given [you] a home testing kit to test for blood 
in the stool? (Given Home Fecal Occult Blood 
Test [FOBT]), n=3,276 
Ever had a colonoscopy or 
sigmoidoscopy, n=3,276 
Sent in most 
recent one, 
n=1,667 
Ever heard of 
home FOBT 
kit, n=1,609 
When was most 
recent one? 
x <1 year 
x 1-2 years 
x 2-3 years 
x 3-5 years 
x >5 years 
(n=1,574) 
 ‡YES 
Ever heard of 
colonoscopy, 
n=1,179 
Did doctor 
recommend 
colonoscopy, 
n=935* 
‡YES
When was most 
recent one? 
x <1 year 
x 1-2 years 
x 2-3 years 
x 3-5 years 
x >5 years 
(n=2,097) 
‡YES NO NO 
‡YES YES 
Figure 1 Design of CRC testing questions on the 2007 Medicare Current Beneficiary Survey with analytic samples (n = 3,276).
‡Participants who had previously heard of or received a screening by FOBT (fecal occult blood test) or sigmoidoscopy/colonoscopy were asked
if they knew that Medicare helps to pay for colon cancer screening, n = 3,130. *Those who have never heard of colonoscopy were considered
not to have previously received a recommendation and thus included in the dominator for this analysis.
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examined for differences in whether or not a beneficiary
returned his/her last home FOBT kit.
Multinomial regression models were used to determine
whether use of an FOBT alone within one year, or colono-
scopy/sigmoidoscopy alone within five years differed
according to PCP specialty. We then used logistic regres-
sion models to examine the association between PCP spe-
cialty and the combined outcome of any CRC screening
exam. Further, we examined two additional outcomes that
involve direct healthcare provider participation as reported
by patients: whether an eligible beneficiary was given an
FOBT kit, or received a colonoscopy recommendation.
Several subgroup and sensitivity analyses were also
performed.
Individual enrollees were the unit of analyses, and we
used data on beneficiaries’ usual PCP and covariates from
the 2006 survey for the analyses. The covariates included
in the regression models (as shown in Table 1) were based
on previous studies [20]. We used cross-sectional survey
weights in all analyses and variance estimation accounted
for the complex survey design. The analyses were per-
formed using STATA version 12.
Results
Characteristics of the study population
A total of 3,276 subjects, representing a weighted sam-
ple of about 14.3 million Medicare enrollees, were
included in the analyses. Of these subjects, 2,629 (81%)
were non-Hispanic whites, 320 (9%) were non-Hispanic
blacks, 224 (7%) were of Hispanic ethnicity and 103
(3%) were of other or unknown race/ethnicity.
After applying sampling weights, about 49% of benefi-
ciaries received their usual care from FPs and 51% from
internists. The characteristics of the study population
according to PCP specialty are shown in Table 1. Com-
pared to internists, a lower percentage of FPs’ patients
were blacks or Hispanics, or resided in a Metropolitan
Service Area (MSA). A lower percentage of patients
receiving care from FPs had high school diploma or
higher, >$25,000 in annual household income, or sup-
plemental insurance. FPs’ patients were more likely to
have been interviewed in English.
Awareness and receipt of home FOBT kits
Among beneficiaries who had not previously had a
home FOBT, about one-half had heard of the test,
Table 1 Characteristics of the study population by primary care physician specialty, MCBS 2006-2007 (n = 3,276)
Characteristic, % General Internist, n = 1,624 Family Physicians, n = 1,652 Wald test p- values
Age, years
50-54 5.1 5.1
55-64 13.2 15.6 0.24
65-69 40.0 40.6
70-75 41.7 38.7
Race/Ethnicity
Whites 77.8 83.0
Blacks 10.5 8.4 0.02
Hispanics 7.8 5.7
Others 3.9 3.0
Female 55.5 54.3 0.54
Married or living together 63.3 63.4 0.94
Residing in Metropolitan Service Area 80.6 66.2 <0.01
Had less than high school diploma 19.1 26.6 <0.01
Annual household income <$25,000 44.4 49.1 0.03
Language of interview, English 95.1 98.2 <0.01
Working at a job 17.8 17.0 0.58
Delayed medical care due to cost 10.8 12.7 0.12
Had supplemental health insurance 74.8 69.7 0.01
Had a history of non-skin cancer 15.4 13.3 0.10
General health fair-to-poor 27.1 28.0 0.54
There were a total of 527 beneficiaries in the sample who were in Medicare because of disabilities. Compared to persons in Medicare because of age-eligibility, a
higher proportion of those with disability were non-Hispanic blacks (8% vs. 18%) or were Hispanic (0.8% vs.2%) (p-value <0.01). They were less likely to be
married (p-value <0.01), have supplemental insurance (p-value <0.01) or have received a high school diploma (p-value <0.01). Beneficiaries with disability were
more likely to report fair or poor health (p-value <0.01), or have an annual income of < $25,000 (p-value <0.01). The proportion receiving care from FPs (53%) or
internists (47%) was similar irrespective of disability status.
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value = 0.15, Table 2). However, a lower percent of
patients receiving care from FPs (48%) than from inter-
nists (54%) had previously been given an FOBT kit
(Figure 2). This difference was statistically significant
even after adjusting for other covariates (adjusted odds
ratio [AOR], 95% confidence intervals [CI]–0.82, 0.69-
0.96). Of those who had previously received an FOBT
kit, about 95% returned their most recent one for testing
and again, this was similar for patients of both FPs and
internists (p-value = 0.27, Table 2).
Awareness of colonoscopy/sigmoidoscopy and receipt of
recommendation
Among patients who had not previously undergone
colonoscopy/sigmoidoscopy, a higher percentage of
patients receiving care from FPs than from internists
had heard of colonoscopy or sigmoidoscopy (82% vs.
77%, p-value = 0.04, Table 2). Only 18% of patients
receiving care from FPs had received a colonoscopy
recommendation compared to 27% receiving care from
internists (Figure 2). The difference in receipt of colono-
scopy recommendation remained statistically significant
even after accounting for the effects of other covariates
(AOR, CI–0.59, 0.44-0.88, Table 3). Compared to per-
sons in Medicare because of age-eligibility, disabled ben-
eficiaries were less likely to report having received a
recommendation for colonoscopy/sigmoidoscopy (25%
vs. 13%, p < .01).
Association between PCP specialty and use of CRC
screening
The percentage of patients having FOBT within the past
year was lower for those receiving care from FPs (10%) as
compared to patients of internists (14%) (Figure 2 and
Table 3). Similarly, the percentage of patients who had
undergone a colonoscopy/sigmoidoscopy within the past
5 years was slightly lower for patients of FPs (43%) than
it was for patients of internists (46%). Analyses on the
combined screening outcome confirmed that a lower per-
centage of beneficiaries receiving care from FPs (52%)
had undergone CRC screening, compared to patients of
internists (60%) (Figure 2). The PCP specialty differences
in receipt of an FOBT alone (AOR, CI-0.65, 0.51-0.8),
colonoscopy/sigmoidoscopy alone (AOR, CI-0.84, 0.71-
1.00), or any screening exam, (AOR, CI-0.80, 0.68-0.94)
remained statistically significant even after controlling for
patients’ characteristics including education, income,
health insurance coverage and place of residence (Table
3).
In subgroup analyses, the highest rates of screening
were observed among beneficiaries with annual house-
hold incomes of $25,000 or higher receiving care from
internists (68%). The lowest rates were among persons
Table 2 Knowledge and awareness of colorectal cancer screening by primary care physician specialty, MCBS 2006-
2007 (n = 3,276)
Interview items CRC screening knowledge and awareness by Specialty % (95% CI)
General Internist, n =
1,624
Family Physicians, n =
1,652
Wald test p-
values
Previously heard of colon cancer 86.6 (84.2-89.0) 86.4 (82.8-90.0) 0.91
Previously heard of colonoscopy* 76.6 (72.3-80.9) 82.1 (78.8-85.4) 0.04
Previously heard of home FOBT kit 50.1 (44.8-55.3) 54.4 (50.4-58.3) 0.15
Returned most recent FOBT kit 94.9 (93.2-96.7) 93.5 (91.5-95.5) 0.27
Knew of Medicare’s benefit for screening stratified by prior receipt of
colonoscopy*
Previously had colonoscopy 57.9 (54.0-61.8) 54.1 (49.9-58.2) 0.12
Not previously had colonoscopy 34.4 (29.7-39.1) 31.7 (28.1-35.3) 0.34
*Refers to colonoscopy or sigmoidoscopy; FOBT Home fecal occult blood test
Figure 2 Percentages of colorectal cancer screening outcomes
by usual primary care physician specialty, MCBS 2006-2007 (n
= 3,276). Notes: †FOBT = Fecal occult blood test. ‡Refers to
colonoscopy or sigmoidoscopy. *Screening defined as receipt of
colonoscopy or sigmoidoscopy within 5 years and/or FOBT within 1
year. All p-values <0.01
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those without a high school diploma (41%) who had
received care from FPs (Table 4). In the subgroups of
patients stratified by race and ethnicity, residence in
MSA, income level, educational achievement and health
insurance type, patients receiving care from FPs had
consistently lower odds of undergoing screening. The
largest relative differences were observed among enrol-
lees aged 50-64 years (OR, CI −0.50, 0.27-0.89), blacks
(OR, CI–0.62, 0.41-0.92) or people with supplemental
insurance (OR, CI–0.77, 0.68-0.87).
Sensitivity analyses
Multivariable analyses, restricted to those who had
reported on the MCBS that an FP (n = 935) or internist
(n = 987) was their usual physician, found that enrollees
seeing FPs were 0.80 (CI: 0.69-0.92) times as likely as
those seeing internists to undergo screening. Analyses
were also performed with CRC screening defined as
receipt of sigmoidoscopy/colonoscopy within 2 years
and/or FOBT within 1 year, while excluding persons who
had sigmoidoscopy/colonoscopy more than 2 years pre-
viously (n = 1,007). Compared to internists, FPs’ patients
were 0.79 (CI: 0.66-0.96) times as likely to have been
screened. Analyses restricted to enrollees 65-75 years old
did not change the findings.
Discussion
This study examined the delivery and receipt of CRC
screening among a nationally representative sample of
Medicare beneficiaries according to the specialty of their
usual PCP. We found that the use of CRC screening tests,
defined in our study as having completed FOBT testing
within one year or sigmoidoscopy or colonoscopy within 5
years, was lower than the national goal of 70% for both
internists and family physicians despite high levels of CRC
screening awareness among beneficiaries. We found that
patients receiving care from FPs had a lower rate of testing
than those receiving care from internists, despite equal or
higher awareness of screening tests among FPs’ patients.
PCP specialty differences were observed for all testing out-
comes examined and remained statistically significant
even after accounting for socioeconomic status of enrol-
lees and factors related to access to health care. Surpris-
ingly, the magnitude of the differences in use of screening
tests was similar across many of the subgroups examined.
The stability of the results across multiple outcomes, sub-
groups and multiple sources of information strengthens
our findings.
We found a wide spectrum in terms of testing rates in
this population. In 2007, 68% Medicare beneficiaries in
higher income groups who received care from internists
had undergone testing, which is nearly at the national
Table 3 Unadjusted and adjusted estimates of the association between PCP specialty and CRC screening practices,
MCBS 2006-2007 (n = 3,276)
Screening outcomes by PCP specialty Unadjusted percent (95% CI) Odds ratios (95% CI)
Unadjusted Adjusted
Logistic regression models analyses
Given home FOBT kit
Internists 54.4 (51.2-57.8) 1.00 (ref) 1.00 (ref)
Family physicians 47.5 (44.2-50.9) 0.76 (0.65,0.89) 0.82 (0.69,0.96)
Recommendation for colonoscopy/sigmoidoscopy
Internists 27.1 (22.6-31.5) 1.00 (ref) 1.00 (ref)
Family physicians 18.0 (14.9-21.2) 0.59 (0.44,0.80) 0.64 (0.47,0.86)
Multinomial models analyses with unscreened as common reference group
Had home FOBT within a year
Internists 14.0 (12-15.9) 1.00 (ref) 1.00 (ref)
Family physicians 9.8 (8.4-11.2) 0.59 (0.47-0.74) 0.65 (0.51-0.81)
Had colonoscopy within 5 years
Internists 46.3 (43.4-49.2) 1.00 (ref) 1.00 (ref)
Family physicians 42.7 (39.7-45.8) 0.77 (0.65-0.92) 0.84 (0.71-1.00)
Logistic regression models analyses
Had CRC screening
Internists 60.2 (57.5-63.0) 1.00 (ref) 1.00 (ref)
Family physicians 52.5 (49.6-55.4) 0.73(0.62,0.86) 0.80 (0.68,0.94)
* Adjusted for age, race, ethnicity, sex, marital status, language of the interview, residence in metropolitan service area, education, annual household income,
delayed medical care due to cost, supplemental insurance, work status, history of non-skin cancer and general health status
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est rate, 34%, among disabled enrollees (50-54 years old)
receiving care from FPs, which was 50% lower than the
rate for this group of enrollees who had received care
from internists. Only about half of eligible patients had
received an FOBT kit, with proportionally fewer of FPs’
patients receiving one. Less than a fifth of beneficiaries
who received care from FPs received a screening colono-
scopy recommendation, compared to about a third of
those who received care from internists.
T oo u rk n o w l e d g e ,n op r e v i o u ss t u d i e sh a v es i m u l t a -
neously examined specialty of usual healthcare provider
and patients’ receipt of CRC screening in a nationally
representative sample. That said, our findings with
respect to specialty differences in screening rates are con-
sistent with previous studies showing that among adult
PCPs, internists have higher rates of providing preventive
care services including cancer screening than FPs [16,17].
A study using Medicare claims data found that patients
receiving care from FPs/GPs were less likely to undergo
CRC screening compared to patients of internists [18].
Our study used data from in-person interviews with
patients, supplemented with insurance claims, and
included analyses on multiple CRC screening outcomes
at both the patient and provider levels. This provides a
more detailed analysis of patient characteristics, patient
knowledge of screening services and use of screening
tests based on the primary care specialist seen.
The most plausible reason for PCP specialty differences
in screening is that family practitioners are less aggressive
about offering CRC testing to their patients. Patients
receiving care from FPs were equally knowledgeable about
CRC screening and Medicare’s benefit for screening, as
those receiving care from internists. In fact, compared to
internists, a higher percentage of patients receiving care
from FPs had heard of colonoscopy, and yet screening-eli-
gible patients of FPs were less likely to have been offered a
home FOBT kit or a recommendation for colonoscopy.
Our findings suggest that once offered screening, the rates
of test completion were similar for both groups of patients.
These findings suggest that the lower rates of CRC screen-
ing are due, in part, to potentially remediable healthcare
provider variations in screening practices and not solely
from patient-related factors or systematic refusal of testing
by patients. Our results show that eliminating PCP varia-
tions in CRC practices has the potential to substantially
increase utilization of CRC screening among a diverse
group of screening-eligible adults.
Table 4 Stratified adjusted estimates of the association between PCP specialty and use of CRC screening, MCBS 2006-
2007 (n = 3,276)
Characteristics Percent screened (95% CI] Odds ratios for FPs relative to internists (95% CI)
Internists Family Physician
Age, yrs
50-54 49.7 (41.5-57.9) 33.6 (23.5-43.7) 0.50 (0.27-0.89)
55-64 48.6 (42.5-54.7) 45.6 (39.7-51.4) 0.93 (0.65-1.33)
65-69 62.2 (59.8-64.7) 56.4 (53.4-59.4) 0.87 (0.75-1.01)
70-75 62.8 (60.0-65.5) 54.0 (51.1-56.9) 0.76 (0.64-0.90)
Race/Ethnicity
Whites 62.0 (59.9-64.1) 54.5 (52.2-56.8) 0.83 (0.73-0.94)
Blacks 60.3 (55.1-65.5) 44.1 (35.3-52.8) 0.62 (0.41-0.92)
Hispanics 50.4 (44.1-56.6) 43.1 (35.3-51.0) 0.75 (0.47-1.19)
Others 41.6 (31.9-51.4) 41.1 (28.5-53.6) 1.08 (0.58-2.01)
Residing in Metropolitan Service Area
No 53.9 (50.1-57.8) 46.0 (41.9-50.0) 0.80 (0.63-1.01)
Yes 61.6 (59.6-63.6) 55.9 (53.7-58.1) 0.81 (0.72-0.91)
Less than high school diploma
No 62.8 (60.7-64.8) 56.8 (54.8-58.9) 0.81 (0.72-0.91)
Yes 48.8 (44.8-52.8) 40.9 (37.2-44.6) 0.79 (0.63-0.98)
Annual household income
>$25,000 67.6 (65.6-69.5) 61.2 (58.8-63.7) 0.80 (0.70-0.92)
<$25,000 50.8 (47.7-54.0) 43.7 (40.4-47.1) 0.81 (0.68-0.97)
Had supplemental health insurance
No 47.5 (43.6-51.3) 43.7 (39.4-48.0) 0.91 (0.73-1.14)
Yes 64.4 (62.4-66.3) 56.4 (54.3-58.5) 0.77 (0.68-0.87)
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alty variations found in this study. Some previous studies
suggest that FPs may be more likely to provide safety-net
care in non-academic and rural settings [17,18]. This
could have a significant impact on recommendation for
colonoscopy as FPs may have less access to subspecialist
referral networks necessary for colonoscopy. Further, FPs
provide a wider scope of services [17], which may lead to
more competing and disparate demands in their practices
than for internists [13]. However, in this study, the differ-
ences persisted even after controlling for patient factors,
suggesting that differences in use of screening tests cannot
be attributed to differences in the complexity of patients’
medical care needs alone.
Organization and style of physician practices, such as
tracking systems for monitoring delivery of CRC screen-
ing services, may contribute to the differences observed
in this study [17,18]. Such practice-related barriers to
providing CRC screening may present greater hurdles for
FPs than internists, particularly in rural and underserved
areas. Tailored practice-based interventions [25] includ-
ing reminder systems [26], clinical outreach, programs to
monitor disparate care in practices, and the use of pre-
ventive medicine specialists, supported by information
technology solutions and incentive programs, may
increase screening within primary care offices. Mitigating
such hurdles has the potential to increase recommenda-
tions of CRC screening in primary care practices.
Limitations and strengths
Measures of CRC testing were based on self-report, which
can be subject to considerable recall bias. Self-report may
overestimate screening rates [27-29], or, on the other
hand, may capture information not captured in claims,
particularly for those with supplemental insurance, who
may not have valid claims in Medicare databases [30].
Also, the use of colonoscopy or sigmoidoscopy was
defined as being within a 5-year time period rather than
the 10-year period recommended by some guidelines. The
screening rates may have been higher if the exposure mea-
surement considered a 10-year period prior to the inter-
view date rather than the interval used for this report.
However, screening colonoscopy was relatively uncom-
mon in the early 2000s [20]. Thus, extending the window
for ascertainment of colonoscopy is unlikely to have a sub-
s t a n t i v ei m p a c to nt h ef i n d i n g s .A l s o ,w ew e r eu n a b l et o
differentiate screening from diagnostic exams. These lim-
itations may result in misclassification of some of the out-
comes studied. The misclassification was likely non-
differential and thus would not have changed our findings.
This study was based on data on Medicare beneficiaries in
the United States and as such, may not be generalized to
other populations or settings with different health care
systems. However, the findings provide important lessons
for evaluating and improving the delivery of cancer screen-
ing services in primary care for a broad range of settings.
Conclusions
The use of CRC screening tests was lower than the
national goal despite high levels of CRC screening
awareness irrespective of whether patients received care
from internists or family physicians. Our results suggest
that potentially remediable variations in practice style or
practice environment contributed to the differences in
screening rates according to PCP specialty. Our study
shows the potential to greatly increase screening rates
nationally through greater efforts to increase physicians’
offering of CRC screening. However, additional studies,
including mixed methods research that capture the
experiences of patients in primary care who have not
undergone testing, may provide data that can be used to
develop interventions to improve delivery of CRC
screening in primary care setting.
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